NCT06941701 Effects of Physical Fatigue on Cognitive Load and Performance Under Dual-Task Environments.
| NCT ID | NCT06941701 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Fatigue |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-04-23 |
| Primary Completion | 2025-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-04-23 with a primary completion date of 2025-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine how different levels of physical fatigue influence cognitive load and performance during dual-task activities. 1. To assess the changes in cognitive task performance under varying levels of physical fatigue. 2. There is an association between cognitive loading and physical fatigue.
Eligibility Criteria
Inclusion Criteria: * Individuals aged 18 to 30 years. * Physically healthy individuals. * Willingness to participate in the study. Exclusion Criteria: * Cognitive Impairment. * Neurological injury. * Cardiac, pulmonary, or inflammatory diseases. * Mental health conditions include depression and post-traumatic stress disorder. * Individuals unwilling to participate.
Contact & Investigator
Imran Amjad, Phd
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06941701 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Fatigue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06941701 currently recruiting?
Yes, NCT06941701 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06941701 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT06941701 clinical trial?
NCT06941701 is sponsored by Riphah International University. The principal investigator is Imran Amjad, Phd at Riphah International University. The trial plans to enroll 90 participants.